Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 12 - 09 symbols : SNYNF save search
Pfizer and BioNTech's Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster Receives Health Canada Authorization for Children 5 Through <12 Years of Age
Published: 2022-12-09 (Crawled : 00:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
covid-19 children vaccine canada health authorization
S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2022 Review Results
Published: 2022-12-09 (Crawled : 23:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
SPGI | News | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
| Email alert
Add to watchlist
NOC | News | $462.58 2.23% 0.07% 950K
|
Electronic Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
CUBE | $42.05 0.45% 0.0% 870K
|
Finance
| Email alert
Add to watchlist
TTFNF | News | $72.26 -3.76% 1.9K
|
Energy Minerals
| Email alert
Add to watchlist
CP | $84.68 0.88% 0.0% 1.6M
|
Transportation
| Email alert
Add to watchlist
review results
Global Pharma, Biotech and Diagnostics Option and Evaluation Partnership Directory 2015-2022
Published: 2022-12-09 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
partnership global biotech diagnostics
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
Published: 2022-12-09 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.06%
H: 2.11%
C: -0.06%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
covid-19 fda designation candidate vaccine influenza fast track designation
Number of Shares and Voting Rights of Innate Pharma as of December 1, 2022
Published: 2022-12-09 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.97%
H: 0.41%
C: -1.07%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 3.41%
H: 2.83%
C: 0.0%
pharma
Feminine hygiene products market size is to grow by USD 11,407.53 million growth opportunities led by Albaad Deutschland GmbH, Fieldstore Ltd, Corman SpA - Technavio
Published: 2022-12-09 (Crawled : 03:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
UNLYF | $47.95 1.3% 740
|
Consumer Non-Durables
|
| O: 2.81%
H: 0.0%
C: -0.82%
HEGIY | $15.901 -10.57% 9.4K
|
Manufacturing
|
| O: 2.48%
H: 0.13%
C: -1.34%
UL | $47.31 0.98% 0.02% 5M
|
Consumer Non-Durables
|
| O: 0.73%
H: 0.32%
C: -0.83%
EPC 4 | $36.65 1.41% 0.0% 260K
|
Consumer Non-Durables
|
| O: -0.46%
H: 0.61%
C: -0.97%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
growth market
Vitamins market to grow by USD 29,240.02 million: Packaged foods and meats products are the parent market - Technavio
Published: 2022-12-09 (Crawled : 03:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.18%
H: 1.63%
C: 0.73%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
foods market
Innovent Presents Phase Ib Clinical Data Update of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 European Society For Medical Oncology Immuno-Oncology Congress
Published: 2022-12-09 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.33%
H: 0.27%
C: -3.22%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.05%
H: 0.4%
C: -2.15%
ibi110 medical update
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.